Iovance Biotherapeutics Inc
IOVA
Market Cap$584.38M
Close$
$-0.17
109.5% downside
Current Fair Value
109.5% downsideOvervalued by 109.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $584.38 Million |
|---|---|
| Enterprise Value | $466.44 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.28 |
| Beta | 0.86 |
| Outstanding Shares | 322,868,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.51 |
|---|---|
| PEG | -53.36 |
| Price to Sales | - |
| Price to Book Ratio | 0.88 |
| Enterprise Value to Revenue | 2.19 |
| Enterprise Value to EBIT | -1.17 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 0.07 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Iovance Biotherapeutics Inc
CEO: Maria Fardis